$Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer$

Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer

Purpose To evaluate the toxicity of pelvic intensity-modulated radiotherapy (IMRT) with hypofractionated simultaneous integrated boost (SIB) to the prostate for patients with intermediate- to high-risk prostate cancer. Methods and Materials A retrospective toxicity analysis was performed in 30 conse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of radiation oncology, biology, physics biology, physics, 2009-10, Vol.75 (2), p.413-420
Hauptverfasser:	McCammon, Robert, M.D, Rusthoven, Kyle E., M.D, Kavanagh, Brian, M.D, Newell, Sherri, B.S, Newman, Francis, M.S, Raben, David, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Androgen Antagonists - therapeutic use ANDROGENS BLADDER Cystitis - etiology Dose Fractionation HAZARDS Hematology, Oncology and Palliative Medicine Humans IMRT Intensity-modulated radiotherapy Intestines - radiation effects LYMPH NODES Lymphatic Irradiation - adverse effects Lymphatic Irradiation - methods Male Middle Aged NEOPLASMS PATIENTS Pelvic Pelvis PROSTATE Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - drug therapy Prostatic Neoplasms - radiotherapy RADIATION DOSES Radiation Injuries - complications Radiography Radiology RADIOLOGY AND NUCLEAR MEDICINE RADIOTHERAPY Radiotherapy, Intensity-Modulated - adverse effects Radiotherapy, Intensity-Modulated - methods RECTUM Retrospective Studies Simultaneous integrated boost TOXICITY Urinary Bladder - radiation effects Urination Disorders - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!